Decision-making regarding anticoagulant therapy in the last phase of life: In-depth interview study with healthcare professionals (the OPTIMA trial)
This study highlighted the complexity of decision-making regarding anticoagulant therapy in the last phase of life. This results, in practice, in reactive instead of proactive decision-making.
Authors
- Marieke J. H. A. Kruip (ORCID: https://orcid.org/0000-0002-0265-4871)
- Eric C. T. Geijteman (ORCID: https://orcid.org/0000-0001-7354-2220)
- P.H.M. van der Kuy (ORCID: https://orcid.org/0000-0002-7128-8801)
- Agnes van der Heide (ORCID: https://orcid.org/0000-0001-5584-4305)
- Marte A.M van Hylckama Vlieg (ORCID: https://orcid.org/0000-0002-1560-1111)
- Carin C.D. van der Rijt (ORCID: https://orcid.org/0000-0001-5996-1242)
- Karlijn J. I. de Beukelaar
- Romy H. L. Spreeuw
Institutions
- Erasmus MC (NL)
- Erasmus MC Cancer Institute (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Palliative Medicine
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1177/02692163251394875
- Primary Topic
- Healthcare cost, quality, practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00